| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 3 securities · may seek to influence control | ||||||
|
Synlogic, Inc.
13D/A
SYBX · 87166L209
|
25.0% |
7/29/2026
Event 7/28/2026
|
||||
| New Enterprise Associates 14, L.P. | 25.0% | |||||
| NEA Partners 14, L.P. | 25.0% | |||||
| Nea 14 GP, Ltd | 25.0% | |||||
| Anthony A. Florence, Jr. | 25.0% | |||||
| Mohamad H. Makhzoumi | 25.0% | |||||
| Scott D. Sandell | 25.0% | |||||
| Forest Baskett | 0% | |||||
| Patrick J. Kerins | 0% | |||||
|
Adaptimmune Therapeutics Plc
13D/A
ADAPY · 00653A107
|
0% |
8/19/2025
Event 8/15/2025
|
||||
| New Enterprise Associates 14, L.P. | 0% | |||||
| NEA Partners 14, L.P. | 0% | |||||
| Nea 14 GP, Ltd | 0% | |||||
| New Enterprise Associates 16, L.P. | 0% | |||||
| NEA Partners 16, L.P. | 0% | |||||
| Nea 16 GP, LLC | 0% | |||||
| Forest Baskett | 0% | |||||
| Anthony A. Florence, Jr. | 0% | |||||
| Patrick J. Kerins | 0% | |||||
| Mohamad H. Makhzoumi | 0% | |||||
| Scott D. Sandell | 0% | |||||
|
NextNav Inc.
13D/A
NN · 65345N106
|
0.1% |
1/7/2025
Event 1/3/2025
|
||||
| New Enterprise Associates 14, L.P. | 0% | |||||
| NEA Partners 14, L.P. | 0% | |||||
| Nea 14 GP, Ltd | 0% | |||||
| Forest Baskett | 0% | |||||
| Anthony A. Florence, Jr. | 0% | |||||
| Patrick J. Kerins | 0.1% | |||||
| Mohamad H. Makhzoumi | 0% | |||||
| Scott D. Sandell | 0% | |||||
| Schedule 13G · 1 security · passive | ||||||
|
Tuya Inc.
13G/A
TUYA · 90114C107
|
7.4% |
2/14/2025
Event 12/31/2024
|
||||
| New Enterprise Associates 14, L.P. | 7.4% | |||||
| NEA Partners 14, L.P. | 7.4% | |||||
| Nea 14 GP, Ltd | 7.4% | |||||
| NEA 15 Opportunity Fund, L.P. | 7.4% | |||||
| NEA Partners 15-OF, L.P. | 7.4% | |||||
| Nea 15 GP, LLC | 7.4% | |||||
| Forest Baskett | 7.4% | |||||
| Anthony A. Florence, Jr. | 7.4% | |||||
| Patrick J. Kerins | 6.7% | |||||
| Mohamad H. Makhzoumi | 7.4% | |||||
| Scott D. Sandell | 7.4% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.